These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23194537)

  • 1. A new QSAR model, for angiotensin I-converting enzyme inhibitory oligopeptides.
    Sagardia I; Roa-Ureta RH; Bald C
    Food Chem; 2013 Feb; 136(3-4):1370-6. PubMed ID: 23194537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity relationship study of bitter di- and tri-peptides including relationship with angiotensin I-converting enzyme inhibitory activity.
    Wu J; Aluko RE
    J Pept Sci; 2007 Jan; 13(1):63-9. PubMed ID: 17117396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Quantitative Structure-Activity Relationship Model for Angiotensin-Converting Enzyme Inhibitory Dipeptides Based on Integrated Descriptors.
    Deng B; Ni X; Zhai Z; Tang T; Tan C; Yan Y; Deng J; Yin Y
    J Agric Food Chem; 2017 Nov; 65(44):9774-9781. PubMed ID: 28984136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification-based QSAR Models for the Prediction of the Bioactivity of ACE-inhibitor Peptides.
    Tripaldi P; Pérez-González A; Rojas C; Radax J; Ballabio D; Todeschini R
    Protein Pept Lett; 2018; 25(11):1015-1023. PubMed ID: 30430931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship.
    Jimsheena VK; Gowda LR
    Peptides; 2010 Jun; 31(6):1165-76. PubMed ID: 20214946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular descriptors of amino acids for the evaluation of the physicochemical parameters and biological activity of peptides].
    Tiunina EIu; Badelin VG
    Bioorg Khim; 2009; 35(4):501-9. PubMed ID: 19928052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
    Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
    Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements of Angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship study of di- and tripeptides.
    Wu J; Aluko RE; Nakai S
    J Agric Food Chem; 2006 Feb; 54(3):732-8. PubMed ID: 16448176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE inhibitory activity.
    Foltz M; van Buren L; Klaffke W; Duchateau GS
    J Food Sci; 2009 Sep; 74(7):H243-51. PubMed ID: 19895477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study on angiotensin-converting enzyme inhibitor oligopeptides based on a novel set of sequence information descriptors.
    Wang X; Wang J; Lin Y; Ding Y; Wang Y; Cheng X; Lin Z
    J Mol Model; 2011 Jul; 17(7):1599-606. PubMed ID: 20941517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory profile of nonapeptide derived from porcine troponin C against angiotensin I-converting enzyme.
    Katayama K; Tomatsu M; Kawahara S; Yamauchi K; Fuchu H; Kodama Y; Kawamura Y; Muguruma M
    J Agric Food Chem; 2004 Feb; 52(4):771-5. PubMed ID: 14969529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chebulin: Terminalia chebula Retz. fruit-derived peptide with angiotensin-I-converting enzyme inhibitory activity.
    Sornwatana T; Bangphoomi K; Roytrakul S; Wetprasit N; Choowongkomon K; Ratanapo S
    Biotechnol Appl Biochem; 2015; 62(6):746-53. PubMed ID: 25410725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of the interactions between inhibitory tripeptides and angiotensin-converting enzyme.
    Zhou M; Du K; Ji P; Feng W
    Biophys Chem; 2012 Jul; 168-169():60-6. PubMed ID: 22835627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling dipeptides as ACE inhibitors and bitter-tasting compounds by means of E-state structure-information representation.
    Spasov B; Hall LH
    Chem Biodivers; 2007 Nov; 4(11):2528-39. PubMed ID: 18027352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae).
    Ni H; Li L; Liu G; Hu SQ
    PLoS One; 2012; 7(5):e37077. PubMed ID: 22606330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SVEEVA descriptor application to peptide QSAR.
    Tong J; Che T; Liu S; Li Y; Wang P; Xu X; Chen Y
    Arch Pharm (Weinheim); 2011 Nov; 344(11):719-25. PubMed ID: 21956614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and activity of ACE inhibitory peptides].
    Ren J; Cao G; Zhang RJ; Li DW; Wei TT; Qin CG
    Yao Xue Xue Bao; 2011 Jan; 46(1):58-63. PubMed ID: 21465810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent production of angiotensin I-converting enzyme inhibitors from buckwheat protein.
    Li CH; Matsui T; Matsumoto K; Yamasaki R; Kawasaki T
    J Pept Sci; 2002 Jun; 8(6):267-74. PubMed ID: 12093003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.